tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Company (TAK)
:TAK
US Market

Takeda Pharmaceutical Company (TAK) Cash flow

Compare
1,332 Followers

Takeda Pharmaceutical Company Cash Flow

TAK's free cash flow for Q2 2025 was ¥325.40B. For the 2025 fiscal year, TAK's free cash flow was decreased by ¥620.77B and operating cash flow was ¥378.23B. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ 1.06T¥ 716.34B¥ 977.16B¥ 1.12T¥ 1.01T
Investing Cash Flow
¥ -367.06B¥ -463.86B¥ -607.10B¥ -198.13B¥ 393.53B
Financing Cash Flow
¥ -751.42B¥ -354.42B¥ -709.15B¥ -1.07T¥ -1.09T
End Cash Position
¥ 385.11B¥ 457.80B¥ 533.53B¥ 849.70B¥ 966.22B
Free Cash Flow
¥ 856.39B¥ 235.61B¥ 343.47B¥ 937.07B¥ 774.46B
Currency in JPY

Takeda Pharmaceutical Company Cash Flow